SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Cardinal Health Inc. – ‘S-3ASR’ on 11/8/22 – ‘EX-5.2’

On:  Tuesday, 11/8/22, at 8:33am ET   ·   Effective:  11/8/22   ·   Accession #:  1193125-22-279740   ·   File #:  333-268237

Previous ‘S-3ASR’:  ‘S-3ASR’ on 8/20/19   ·   Latest ‘S-3ASR’:  This Filing   ·   13 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/08/22  Cardinal Health Inc.              S-3ASR     11/08/22    6:462K                                   Donnelley … Solutions/FA

Automatic Shelf Registration Statement by a Well-Known Issuer   —   Form S-3

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-3ASR      Automatic Shelf Registration Statement by a         HTML    282K 
                Well-Known Issuer                                                
 2: EX-5.1      Opinion of Counsel re: Legality                     HTML     36K 
 3: EX-5.2      Opinion of Counsel re: Legality                     HTML     12K 
 4: EX-23.1     Consent of Expert or Counsel                        HTML      6K 
 5: EX-25       Statement of Eligibility to Act as a Trustee        HTML     58K 
 6: EX-FILING FEES  Filing Fees                                     HTML     30K 


‘EX-5.2’   —   Opinion of Counsel re: Legality


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



  EX-5.2  

Exhibit 5.2

November 8, 2022

Cardinal Health, Inc.

7000 Cardinal Place

Dublin, OH 43017

Ladies and Gentlemen:

I am Senior Vice President, Deputy General Counsel and Corporate Secretary of Cardinal Health, Inc., an Ohio Corporation (the “Company”), and I have acted as counsel to the Company in connection with the preparation and filing by the Company of a registration statement on Form S-3 (the “Registration Statement”) with the Securities and Exchange Commission (the “Commission”) relating to the offering from time to time, pursuant to Rule 415 of the Securities Act of 1933, as amended (the “Securities Act”), of (i) Class A common shares, without par value, of the Company (the “Common Shares”), (ii) preferred shares, without par value, of the Company (the “Preferred Shares”), (iii) one or more series of debt securities of the Company (the “Debt Securities”), and (iv) units of the Company comprised of any combination of Common Shares, Preferred Shares, or Debt Securities (the “Units”, and together with the Common Shares, the Preferred Shares, and the Debt Securities, “Offered Securities”). The Debt Securities will be issued in one or more series pursuant to an Indenture dated as of June 2, 2008 (the “Base Indenture”), between the Company and The Bank of New York Mellon Trust Company, N.A. (formerly The Bank of New York Trust Company, N.A.), as trustee (the “Trustee”), which is filed as an exhibit to the Company’s Form 8-K dated June 2, 2008 and incorporated by reference as an exhibit to the Registration Statement. The offering of the Offered Securities will be as set forth in the prospectus contained in the Registration Statement (the “Prospectus”), as supplemented by one or more supplements to the Prospectus.

In rendering this opinion, I have examined the Registration Statement and the Indenture. I have also examined originals or copies, certified or otherwise identified to my satisfaction, of those documents and instruments filed as exhibits to the Registration Statement, such corporate records of the Company, certificates or documents and have made such other investigations and reviewed such questions of law as I have deemed necessary or appropriate for purposes of rendering this opinion.

In the examination of the foregoing and in rendering this opinion, I have assumed the genuineness, without independent investigation, of all signatures on all documents, the legal capacity of each signatory to such documents, the conformity to original documents of all documents submitted for my examination as copies and the authenticity of all such documents.

Based on the foregoing, and subject to the qualifications hereinafter set forth, I am of the opinion that:

1. The Common Shares will be validly issued, fully paid and non-assessable when: (a) final resolutions shall have been duly adopted pursuant to authority granted by the Company’s Board of Directors, authorizing the issuance and sale of the Common Shares, in conformity with the Company’s Amended and Restated Articles of Incorporation, as amended (the “Articles”), and the Common Shares are issued in a manner consistent therewith and assuming the Company shall have such number of Common Shares as are included in such offering or sale authorized and available for issuance; (b) the certificates, if any, representing the Common Shares in the form of the specimen certificate examined by me shall have been duly executed, countersigned and registered; and (c) such Common Shares shall have been duly delivered to the purchasers thereof against payment of the agreed consideration therefor.

2. The Preferred Shares will be validly issued, fully paid and non-assessable when: (a) final resolutions shall have been duly adopted pursuant to authority granted by the Company’s Board of


Directors, authorizing the issuance and sale of the Preferred Shares, in conformity with the Articles, and the Preferred Shares are issued in a manner consistent therewith and assuming the Company shall have such number of Preferred Shares as are included in such offering or sale authorized and available for issuance; (b) all corporate action necessary for the issuance and sale of the shares of Preferred Shares has been taken, including the adoption and filing of an amendment to the Articles relating thereto; (c) the certificates, if any, representing the Preferred Shares in the form of the specimen certificate examined by me shall have been duly executed, countersigned and registered; and (d) such Preferred Shares shall have been duly delivered to the purchasers thereof against payment of the agreed consideration therefor.

3. The Indenture has been duly authorized, executed and delivered by the Company.

This opinion is limited to matters of the laws of the State of Ohio and United States federal law. Accordingly, I express no opinion as to the law of any other domestic or foreign jurisdiction. This opinion is rendered as of the date hereof and I assume no obligation to update or supplement such opinion to reflect any circumstances which may hereafter come to my attention with respect to such opinion and statements set forth above, including any changes in applicable law which may hereafter occur. Furthermore, this opinion is limited to the opinions expressly stated herein. No implication shall be drawn from anything herein that has the effect of extending any such opinion beyond what is expressly stated in such opinion.

I hereby consent to the filing of this opinion letter as an exhibit to the Registration Statement and to the use of my name under the heading “Validity of the Securities” in the Prospectus. In giving this consent, I do not hereby admit that I am in the category of persons whose consent is required under Section 7 of the Securities Act or the rules and regulations of the Commission promulgated thereunder.

 

Very truly yours,
/s/ Patrick Pope
Patrick Pope

Senior Vice President, Deputy General Counsel

& Corporate Secretary

Cardinal Health, Inc.

 

2


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘S-3ASR’ Filing    Date    Other Filings
Filed on / Effective on:11/8/22S-8
6/2/088-K
 List all Filings 


13 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/04/22  Cardinal Health Inc.              10-Q        9/30/22   70:6.5M
10/04/22  Cardinal Health Inc.              8-K:1,9     9/30/22   11:1.6M
 9/28/22  Cardinal Health Inc.              DEF 14A    11/09/22    2:6.5M                                   Labrador Co./FA
 9/08/22  Cardinal Health Inc.              8-K:5,7,9   9/07/22   11:193K
 9/06/22  Cardinal Health Inc.              8-K:1,5,7,9 9/05/22   12:340K
 8/11/22  Cardinal Health Inc.              8-K:5,7,9   8/07/22   10:174K
 8/11/22  Cardinal Health Inc.              10-K        6/30/22  119:15M
 7/22/22  Cardinal Health Inc.              8-K:8,9     7/18/22   13:401K
11/09/21  Cardinal Health Inc.              10-Q        9/30/21   74:7M
 8/20/19  Cardinal Health Inc.              10-K        6/30/19  130:20M
11/07/08  Cardinal Health Inc.              10-Q        9/30/08   13:968K                                   Donnelley … Solutions/FA
 6/02/08  Cardinal Health Inc.              8-K:8,9     6/02/08    6:491K                                   Bowne BCL/FA
 8/24/01  Cardinal Health Inc.              10-K405     6/30/01   10:250K                                   Bowne BCL/FA
Top
Filing Submission 0001193125-22-279740   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., May 10, 11:19:55.2am ET